Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review

Abstract

Alarmins are endogenous mediators released by cells following insults or cell death to alert the host's innate immune system of a situation of danger or harm. Many of these, such as high-mobility group box-1 and 2 (HMGB1, HMGB2) and S100 (calgranulin proteins), act through RAGE (receptor for advanced glycation end products), whereas the IL-1 and IL-33 cytokines bind the IL-1 receptors type I and II, and the cellular receptor ST2, respectively. The alarmin family and their signal pathways share many similarities of cellular and tissue localization, functions, and involvement in various physiological processes and inflammatory diseases including osteoporosis. The aim of the review was to evaluate the role of alarmins in osteoporosis. A bibliographic search of the published scientific literature regarding the role of alarmins in osteoporosis was organized independently by two researchers in the following scientific databases: Pubmed, Scopus, and Web of Science. The keywords used were combined as follows: "alarmins and osteoporosis", "RAGE and osteoporosis", "HMGB1 and osteoporosis", "IL-1 and osteoporosis", "IL 33 and osteopororsis", "S100s protein and osteoporosis". The information was summarized and organized in the present review. We highlight the emerging roles of alarmins in various bone remodeling processes involved in the onset and development of osteoporosis, as well as their potential role as biomarkers of osteoporosis severity and progression. Findings of the research suggest a potential use of alarmins as pharmacological targets in future therapeutic strategies aimed at preventing bone loss and fragility fractures induced by aging and inflammatory diseases.

Keywords: HMGB1 osteoporis; IL-1 osteoporosis; IL-33 osteoporosis; RAGE osteoporosis; S100 calgranulin proteins osteoporosis; alarmins osteoporosis; osteoporosis.

Figure 1

Proposed mechanism of alarmins. (1) Involvement in osteoporosis. Robaszkiewicz et al. 2016, [81]; (2) De Martinis et al., 2020, [84]; (3) Schulze et al., 2011 [101]; (4) Saleh et al., 2011 [103]; (5) Feng et al., 2016, [32]; (6) Li et al., 2016, [34]; (7) Zhou and Xiong, 2011 [24]; (8) Yamamoto et al., 2009. [21].